Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

NICE reaffirms positive opinion on Multaq

July 19, 2010 Sales and Marketing Multaq, NICE, antiarrhythmic, dronedarone

In its final draft guidance, UK cost-effectiveness body NICE has reaffirmed its previous positive opinion to recommend the limited use …
News

GSK takes £1.58bn hit from legal disputes

July 16, 2010 Sales and Marketing Avandia, GlaxoSmithKline, Paxcil, Seroxat

GlaxoSmithKline is set to pay £1.58 billion to settle three long-standing legal disputes, including litigation costs for its troubled diabetes …
News

Changing business models top pharma concerns

July 16, 2010 Sales and Marketing Cegedim, industry, survey

The changing face of pharma business models is the main thing keeping US executives awake at night, according to a …
News

What might the NHS white paper mean for Pharma commercial models?

July 16, 2010 Sales and Marketing Kinapse, NHS, White paper, commercial model, life sciences, pharma

Earlier this year we published a white paper on the new commercial realities and their implications for Life Sciences companies.
Feature
Thought Leadership

Olivier Bohuon joins Pierre Fabre

July 16, 2010 Sales and Marketing Abbott, Pierre Fabre, appointment, sales and marketing

Olivier Bohuon is to replace Jean-Pierre Garnier as the head of French pharma company Pierre Fabre from September. Bohuon is …
Appointment

Best GPs will outperform PCTs, says PCT leader

July 15, 2010 Sales and Marketing NHS, commissioning

The leader of the PCT managers’ organisation David Stout and Mark Britnell, the architect of the former Labour government’s commissioning …
News

New products spur Novartis growth

July 15, 2010 Sales and Marketing Novartis, Tasigna

Novartis has posted strong results for the second quarter of the year. The Swiss pharma company posted an 11% rise …
News
john-beighton

Goldshield appoints John Beighton

July 15, 2010 Sales and Marketing Goldshield, appointment, sales and marketing

UK generics company Goldshield has appointed John Beighton as chief executive. Beighton was formerly UK managing director of Teva, and …
Appointment
John-Castellani

John Castellani to lead PhRMA

July 15, 2010 Sales and Marketing PhRMA, appointment, sales and marketing

US pharma association PhRMA has appointed John Castellani president and chief executive, with effect from September. He will join the …
Appointment
Avandia

GSK accused of Avandia cover-up

July 14, 2010 Sales and Marketing Avandia, GlaxoSmithKline, diabetes

The ongoing battle over GlaxoSmithKline’s diabetes drug Avandia has taken another turn with US senators accusing the company of a …
News
Andrew Lansley

Value-based pricing for UK pharma by 2014

July 13, 2010 Sales and Marketing government, pricing

The UK government plans to radically overhaul the way medicines are paid for, introducing a value-based pricing system within the …
News
Privates game

Digital Pharma: Byte-sized roundup

July 12, 2010 Medical Communications, Sales and Marketing Code of Practice, Digital Pharma blog, digi game, disease awareness campaigns

This week’s roundup includes a sexual health computer game, a powerful new search tool, US health apps and a reprimand …
News
Avastin packshot

Avandia to face European safety review

July 12, 2010 Sales and Marketing Avandia, GlaxoSmithKline, diabetes

GlaxoSmithKline’s type II diabetes drug Avandia, the subject of safety concerns since its launch in 2000, is to be reviewed …
News

NICE rejects Takeda cancer drug over price concerns

July 12, 2010 Sales and Marketing Cancer, Mepact, NICE, Takeda, bone cancer

UK cost-effectiveness watchdog NICE has rejected Takeda’s orphan bone cancer drug Mepact due to concerns over price. In its draft …
News

First oral MS treatment approved in Russia

July 12, 2010 Sales and Marketing Cladribine, MS, Merck Serono, Movectro

Regulators in Russia have approved Merck Serono’s cladribine, lining up the drug to be the first oral treatment for multiple …
News
The Gateway to Local Adoption Series

Latest content

NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma

October 8, 2026

AstraZeneca’s Trixeo approved in EU for asthma

October 8, 2026

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026